Sphera Funds Management’s Kite Pharma, Inc. KITE Stock Holding History

Sphera Funds Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-35,000	Closed	-$2.75M	–	151
2017 Q1	$2.75M	Sell	35,000 -15,000	-30%	-$928K	0.54%	51
2016 Q4	$2.24M	Hold	50,000	–	–	0.57%	52
2016 Q3	$2.79M	Hold	50,000	–	–	0.45%	57
2016 Q2	$2.5M	Hold	50,000	–	–	0.65%	46
2016 Q1	$2.3M	Hold	50,000	–	–	0.5%	40
2015 Q4	$3.08M	Sell	50,000 -6,970	-12%	-$491K	0.45%	54
2015 Q3	$3.17M	Hold	56,970	–	–	0.4%	53
2015 Q2	$3.47M	Sell	56,970 -9,000	-14%	-$513K	0.34%	71
2015 Q1	$3.81M	Sell	65,970 -45,000	-41%	-$3.02M	0.4%	61
2014 Q4	$6.4M	Buy	110,970 +43,000	+63%	+$1.81M	1.09%	21
2014 Q3	$1.94M	Buy	+67,970	New	+$1.68M	0.24%	89

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sphera Funds Management's KITE Position: Q2 2017 in Review

Sphera Funds Management sold out of Kite Pharma, Inc. (KITE) in Q2 2017, closing a stake of 35,000 shares — an estimated $2.75M sold.

Sphera Funds Management first reported a position in KITE in Q3 2014 and held it in 11 quarters. The position peaked at $6.4M in Q4 2014. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

Sphera Funds Management reported no remaining Kite Pharma, Inc. position as of Q2 2017 after selling out during the quarter.
Sphera Funds Management sold 35,000 Kite Pharma, Inc. shares in Q2 2017, an estimated $2.75M.
Sphera Funds Management first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 11 quarters.
Sphera Funds Management's Kite Pharma, Inc. position peaked at $6.4M in Q4 2014.
220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on Sphera Funds Management's 13F filing for Q2 2017, filed 9 Aug 2017.